Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Psoriasis is an autoimmune skin disease that causes scaling, skin redness and irritation. Psoriasis causes red, scaly patches that are generally found on the elbows, fingernails, scalp, palms, knees, face, feet and inside the mouth. Factors that can trigger psoriasis include infections, heavy alcohol consumption, cold weather, certain medications, smoking, stress and injury to the skin such as bug bite, cut and sever sunburn. The signs and symptoms of psoriasis vary from person to person which includes dry, cracked skin that may bleed, red patches of skin covered with silvery scales, small scaling spots, itching, burning, swollen and stiff joints. Psoriasis may be classified into various types such as plaque psoriasis, scalp psoriasis, pustular psoriasis, psoriatic arthritis, guttate psoriasis, nail psoriasis, erythrodermic psoriasis and inverse psoriasis. Various treatments for psoriasis are oral medication, topical medication and biologics injections. Psoriasis can also be treating by phototherapy treatment which includes ultraviolet light therapy, laser treatment, tanning beds, psoralen +UVA and sunlight treatment. Psoriasis can occur in any part of the body and it is associated with other health conditions such as heart disease, diabetes and depression.
One trend resulting in the strong growth of this market is the advent of biologics with novel MOA and cell-based strategies. This market is expected to witness the launch of biologic agents that target the disease pathway specifically, including IL-17/IL-17R receptor inhibitors. Drugs such as brodalumab, guselkumab, and tildrakizumab are undergoing Phase III clinical trials.Factors such as the dominance of market by biologics will drive this market's growth prospects for the near future. Biologics account for over 18% of the global pharmaceutical sales, outpacing the sales of branded pharmaceuticals. These drugs will continue to outperform other pharmaceuticals in terms of product sales as there is an increasing need for innovative products as effective treatment options for a range of indications.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Systemic Psoriasis Therapeutics market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Systemic Psoriasis Therapeutics market. Detailed analysis of key players, along with key growth strategies adopted by Systemic Psoriasis Therapeutics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Amgen
Johnson and Johnson
Celgene
Pfizer
AbbVie
By Type:
Biologics
Small Molecules
By End-User:
Mild Psoriasis
Moderate Psoriasis
Severe Psoriasis
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Systemic Psoriasis Therapeutics Market
-
1.3 Market Segment by Type
-
1.3.1 USA Systemic Psoriasis Therapeutics Market Size and Growth Rate of Biologics from 2016 to 2027
-
1.3.2 USA Systemic Psoriasis Therapeutics Market Size and Growth Rate of Small Molecules from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Systemic Psoriasis Therapeutics Market Size and Growth Rate of Mild Psoriasis from 2016 to 2027
-
1.4.2 USA Systemic Psoriasis Therapeutics Market Size and Growth Rate of Moderate Psoriasis from 2016 to 2027
-
1.4.3 USA Systemic Psoriasis Therapeutics Market Size and Growth Rate of Severe Psoriasis from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Systemic Psoriasis Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Systemic Psoriasis Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Systemic Psoriasis Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Systemic Psoriasis Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Systemic Psoriasis Therapeutics Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Systemic Psoriasis Therapeutics by Major Types
-
3.4.1 Market Size and Growth Rate of Biologics
-
3.4.2 Market Size and Growth Rate of Small Molecules
4 Segmentation of Systemic Psoriasis Therapeutics Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Systemic Psoriasis Therapeutics by Major End-Users
-
4.4.1 Market Size and Growth Rate of Systemic Psoriasis Therapeutics in Mild Psoriasis
-
4.4.2 Market Size and Growth Rate of Systemic Psoriasis Therapeutics in Moderate Psoriasis
-
4.4.3 Market Size and Growth Rate of Systemic Psoriasis Therapeutics in Severe Psoriasis
5 Market Analysis by Regions
-
5.1 USA Systemic Psoriasis Therapeutics Production Analysis by Regions
-
5.2 USA Systemic Psoriasis Therapeutics Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Systemic Psoriasis Therapeutics Landscape Analysis
-
6.1 West USA Systemic Psoriasis Therapeutics Landscape Analysis by Major Types
-
6.2 West USA Systemic Psoriasis Therapeutics Landscape Analysis by Major End-Users
7 South USA Systemic Psoriasis Therapeutics Landscape Analysis
-
7.1 South USA Systemic Psoriasis Therapeutics Landscape Analysis by Major Types
-
7.2 South USA Systemic Psoriasis Therapeutics Landscape Analysis by Major End-Users
8 Middle West USA Systemic Psoriasis Therapeutics Landscape Analysis
-
8.1 Middle West USA Systemic Psoriasis Therapeutics Landscape Analysis by Major Types
-
8.2 Middle West USA Systemic Psoriasis Therapeutics Landscape Analysis by Major End-Users
9 Northeast USA Systemic Psoriasis Therapeutics Landscape Analysis
-
9.1 Northeast USA Systemic Psoriasis Therapeutics Landscape Analysis by Major Types
-
9.2 Northeast USA Systemic Psoriasis Therapeutics Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Amgen
-
10.1.1 Amgen Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Johnson and Johnson
-
10.2.1 Johnson and Johnson Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Celgene
-
10.3.1 Celgene Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Pfizer
-
10.4.1 Pfizer Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 AbbVie
-
10.5.1 AbbVie Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Systemic Psoriasis Therapeutics Market Size and Growth Rate of Biologics from 2016 to 2027
-
Figure USA Systemic Psoriasis Therapeutics Market Size and Growth Rate of Small Molecules from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Systemic Psoriasis Therapeutics Market Size and Growth Rate of Mild Psoriasis from 2016 to 2027
-
Figure USA Systemic Psoriasis Therapeutics Market Size and Growth Rate of Moderate Psoriasis from 2016 to 2027
-
Figure USA Systemic Psoriasis Therapeutics Market Size and Growth Rate of Severe Psoriasis from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Systemic Psoriasis Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Systemic Psoriasis Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Systemic Psoriasis Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Systemic Psoriasis Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Systemic Psoriasis Therapeutics Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Systemic Psoriasis Therapeutics
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Systemic Psoriasis Therapeutics by Different Types from 2016 to 2027
-
Table Consumption Share of Systemic Psoriasis Therapeutics by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Biologics
-
Figure Market Size and Growth Rate of Small Molecules
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Systemic Psoriasis Therapeutics by Different End-Users from 2016 to 2027
-
Table Consumption Share of Systemic Psoriasis Therapeutics by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Mild Psoriasis
-
Figure Market Size and Growth Rate of Moderate Psoriasis
-
Figure Market Size and Growth Rate of Severe Psoriasis
-
Table USA Systemic Psoriasis Therapeutics Production by Regions
-
Table USA Systemic Psoriasis Therapeutics Production Share by Regions
-
Figure USA Systemic Psoriasis Therapeutics Production Share by Regions in 2016
-
Figure USA Systemic Psoriasis Therapeutics Production Share by Regions in 2021
-
Figure USA Systemic Psoriasis Therapeutics Production Share by Regions in 2027
-
Table USA Systemic Psoriasis Therapeutics Consumption by Regions
-
Table USA Systemic Psoriasis Therapeutics Consumption Share by Regions
-
Figure USA Systemic Psoriasis Therapeutics Consumption Share by Regions in 2016
-
Figure USA Systemic Psoriasis Therapeutics Consumption Share by Regions in 2021
-
Figure USA Systemic Psoriasis Therapeutics Consumption Share by Regions in 2027
-
Table West USA Systemic Psoriasis Therapeutics Consumption by Types from 2016 to 2027
-
Table West USA Systemic Psoriasis Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure West USA Systemic Psoriasis Therapeutics Consumption Share by Types in 2016
-
Figure West USA Systemic Psoriasis Therapeutics Consumption Share by Types in 2021
-
Figure West USA Systemic Psoriasis Therapeutics Consumption Share by Types in 2027
-
Table West USA Systemic Psoriasis Therapeutics Consumption by End-Users from 2016 to 2027
-
Table West USA Systemic Psoriasis Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Systemic Psoriasis Therapeutics Consumption Share by End-Users in 2016
-
Figure West USA Systemic Psoriasis Therapeutics Consumption Share by End-Users in 2021
-
Figure West USA Systemic Psoriasis Therapeutics Consumption Share by End-Users in 2027
-
Table South USA Systemic Psoriasis Therapeutics Consumption by Types from 2016 to 2027
-
Table South USA Systemic Psoriasis Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure South USA Systemic Psoriasis Therapeutics Consumption Share by Types in 2016
-
Figure South USA Systemic Psoriasis Therapeutics Consumption Share by Types in 2021
-
Figure South USA Systemic Psoriasis Therapeutics Consumption Share by Types in 2027
-
Table South USA Systemic Psoriasis Therapeutics Consumption by End-Users from 2016 to 2027
-
Table South USA Systemic Psoriasis Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Systemic Psoriasis Therapeutics Consumption Share by End-Users in 2016
-
Figure South USA Systemic Psoriasis Therapeutics Consumption Share by End-Users in 2021
-
Figure South USA Systemic Psoriasis Therapeutics Consumption Share by End-Users in 2027
-
Table Middle West USA Systemic Psoriasis Therapeutics Consumption by Types from 2016 to 2027
-
Table Middle West USA Systemic Psoriasis Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Systemic Psoriasis Therapeutics Consumption Share by Types in 2016
-
Figure Middle West USA Systemic Psoriasis Therapeutics Consumption Share by Types in 2021
-
Figure Middle West USA Systemic Psoriasis Therapeutics Consumption Share by Types in 2027
-
Table Middle West USA Systemic Psoriasis Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Systemic Psoriasis Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Systemic Psoriasis Therapeutics Consumption Share by End-Users in 2016
-
Figure Middle West USA Systemic Psoriasis Therapeutics Consumption Share by End-Users in 2021
-
Figure Middle West USA Systemic Psoriasis Therapeutics Consumption Share by End-Users in 2027
-
Table Northeast USA Systemic Psoriasis Therapeutics Consumption by Types from 2016 to 2027
-
Table Northeast USA Systemic Psoriasis Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Systemic Psoriasis Therapeutics Consumption Share by Types in 2016
-
Figure Northeast USA Systemic Psoriasis Therapeutics Consumption Share by Types in 2021
-
Figure Northeast USA Systemic Psoriasis Therapeutics Consumption Share by Types in 2027
-
Table Northeast USA Systemic Psoriasis Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Systemic Psoriasis Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Systemic Psoriasis Therapeutics Consumption Share by End-Users in 2016
-
Figure Northeast USA Systemic Psoriasis Therapeutics Consumption Share by End-Users in 2021
-
Figure Northeast USA Systemic Psoriasis Therapeutics Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Amgen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen
-
Figure Sales and Growth Rate Analysis of Amgen
-
Figure Revenue and Market Share Analysis of Amgen
-
Table Product and Service Introduction of Amgen
-
Table Company Profile and Development Status of Johnson and Johnson
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson and Johnson
-
Figure Sales and Growth Rate Analysis of Johnson and Johnson
-
Figure Revenue and Market Share Analysis of Johnson and Johnson
-
Table Product and Service Introduction of Johnson and Johnson
-
Table Company Profile and Development Status of Celgene
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene
-
Figure Sales and Growth Rate Analysis of Celgene
-
Figure Revenue and Market Share Analysis of Celgene
-
Table Product and Service Introduction of Celgene
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of AbbVie
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie
-
Figure Sales and Growth Rate Analysis of AbbVie
-
Figure Revenue and Market Share Analysis of AbbVie
-
Table Product and Service Introduction of AbbVie
-
